Moreover, targeting NRF2 can upregulate PHKG2, promote ferritin phagocytosis, enhance radiation-induced mitochondrial dysfunction, thereby increasing the sensitivity of NSCLC to radiation therapy (Fig. 7). This evidence concerns the gene PHKG2 and non-small cell lung carcinoma.